课题基金 / 基金详情

B versus T cells: Effective Mediators of Immunity against Human Viral Infections

B versus T cells: Effective Mediators of Immunity against Human Viral Infections
B 细胞与 T 细胞：对抗人类病毒感染的有效免疫介质
批准号：
365706
负责人：
Shoukry Naglaa H
金额：
$0.73万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-02-01 至 2018-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365706&lang=en
关键词：
Antibodies B Cells Cytokines Hepatitis B Hepatitis C Hiv Influenza T Cells Vaccines

项目摘要

项目成果

Shoukry Naglaa H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite the progress that has been made in understanding the immune response to viral infections, we still do not have effective vaccines against chronic viruses like human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Earlier efforts have foc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex-Dependent Role of IL22 during Metabolic Dysfunction-associated Liver Disease (MASLD)
Canadian Network on Hepatitis C (CanHepC): From Discovery to Implementation
Signatures of protective immunity against HCV
The National CIHR Hepatitis C Network (NCHCN)
海外基金